Pharma Pulse 10/22/24: Harmonizing Data in Clinical Research, A New Type of Gene Therapy & more

Harmonizing Data in Clinical Research

In a recent video interview with Applied Clinical Trials, Silvio Galea, chief data & analytics officer, WCG, discussed the challenges in the clinical trial industry, emphasizing low awareness among both patients and providers. He highlighted operational issues, including the difficulty in identifying and engaging patients, data interoperability, and ensuring data quality. Galea stressed the importance of user experience in electronic data capture tools and the need for industry standards. Prioritizing data collection should focus on safety, efficacy, and efficiency, ensuring data quality, and avoiding workflow disruptions.

A New Type of Gene Therapy Shows Promise for Treating Retinitis Pigmentosa

Up to half of patients showed significant improvement in study results presented at the American Academy of Ophthalmology (AAO) annual meeting.

‘It’s Spare Parts for People’: Blood Vessels Grown in a Lab

Scientists have grown arteries using human cells to better treat injured patients. They have already been effective in Ukrainian soldiers.

GE HealthCare Announces AI Innovation Lab Showcasing Five New Research Projects

GE HealthCare announced a new AI Innovation Lab, an initiative designed to accelerate early-concept AI innovations within the company. These projects are one part of GE HealthCare’s broader AI and digital strategy, which is focused on integrating AI into medical devices, building AI applications that enhance decision-making across the care journey and disease states, and using AI to support better outcomes and operational efficiencies system-wide. The company’s investment in cloud technology underpins this strategy, providing the computing power to drive the development of AI at scale.

Miranda Schmalfuhs on LinkedIn

I hope you've been enjoying my talk with Amanda so far, catch the next part below!

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs